Zelira Therapeutics Limited
ZLDAF
$0.2992
$0.041616.15%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -785.40K | -807.60K | -802.00K | -800.40K | -11.12M |
| Total Depreciation and Amortization | 48.90K | 50.30K | 66.70K | 66.60K | 90.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -121.10K | -124.50K | -710.20K | -708.70K | 10.47M |
| Change in Net Operating Assets | -- | -- | 570.20K | 569.10K | -- |
| Cash from Operations | -857.60K | -881.80K | -875.20K | -873.40K | -564.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 303.00K | 302.40K | -- |
| Cash from Investing | -- | -- | 303.00K | 302.40K | -- |
| Total Debt Issued | 1.05M | 1.05M | 1.13M | 1.13M | 831.90K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 683.60K | 702.90K | 744.70K | 743.20K | 542.20K |
| Foreign Exchange rate Adjustments | -4.50K | -4.70K | -800.00 | -800.00 | -4.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -178.50K | -183.60K | 171.80K | 171.40K | -26.50K |